As of Apr 17
| -0.18 / -2.52%|
The 5 analysts offering 12-month price forecasts for Cytokinetics Inc have a median target of 14.00, with a high estimate of 18.00 and a low estimate of 9.00. The median estimate represents a +101.44% increase from the last price of 6.95.
The current consensus among 5 polled investment analysts is to Buy stock in Cytokinetics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.